James Ryan Mark

机构：Fox Chase Cancer Center, Thomas Jefferson University · ORCID：0000-0001-7675-3437

发表论文 668 篇 · 总被引 949 次 · h-index 13

代表论文

• Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1) (2024 · Journal of Clinical Oncology · 被引 54)
• A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2). (2025 · Journal of Clinical Oncology · 被引 27)
• Risk of Secondary Malignancies After Pelvic Radiation: A Population-based Analysis (2024 · European Urology Open Science · 被引 15)
• TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing (2024 · JCO Precision Oncology · 被引 11)
• Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative (2023 · Urologic Oncology Seminars and Original Investigations · 被引 11)
• A Narrative Review on Robotic Surgery as Treatment for Renal Cell Carcinoma with Inferior Vena Cava Thrombus (2024 · Journal of Clinical Medicine · 被引 8)